Omnicell (OMCL)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
$38.03-3.50%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
QuarterlyIQ Insights · OMCL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 1,243.9 | 1,184.8 | 1,112.2 | 1,147.1 | 1,295.9 | 1,132.0 | 892.2 | 897.0 | 787.3 | 712.7 | 695.9 | 484.6 | 440.9 | 380.6 | 314.0 | 245.5 |
| Total Revenues | — | — | — | — | — | — | — | — | 787.3 | 712.7 | 695.9 | 484.6 | 440.9 | 380.6 | 314.0 | 245.5 |
| Cost of Revenues | 682.5 | 681.4 | 641.2 | 650.3 | 707.0 | 577.4 | 478.9 | 460.1 | 415.0 | 394.1 | 378.8 | 236.6 | 207.0 | 177.2 | 143.4 | 109.8 |
| Gross Profit | 561.4 | 503.4 | 471.0 | 496.8 | 589.0 | 554.7 | 413.3 | 436.9 | 372.3 | 318.6 | 317.1 | 247.9 | 233.9 | 203.4 | 170.6 | 135.8 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 410.1 | 409.6 | 380.3 | 434.6 | 486.3 | 389.4 | 307.6 | 289.9 | 263.1 | 241.5 | 237.9 | 167.6 | 156.5 | 139.0 | 119.7 | 97.5 |
| R&D Expenses | 86.7 | 88.7 | 90.4 | 97.1 | 105.0 | 75.7 | 70.2 | 68.6 | 64.8 | 66.0 | 57.8 | 35.2 | 27.8 | 29.1 | 23.7 | 22.0 |
| Operating Income | 64.7 | 5.2 | 0.3 | (34.9) | (2.3) | 89.5 | 35.5 | 78.4 | 44.4 | 11.1 | 21.4 | 48.6 | 49.6 | 35.3 | 27.1 | 16.2 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.1 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.3 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | (0.2) |
| Other Non-Operating Income / Expenses | 2.6 | 6.2 | 25.3 | 14.8 | (0.1) | (23.5) | (6.2) | (4.4) | (8.8) | (6.6) | (8.4) | (2.4) | (1.1) | — | — | — |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.4 | — | — | — |
| EBT, Incl. Unusual Items | 67.2 | 11.3 | 25.6 | (20.1) | (2.5) | 66.0 | 29.3 | 73.9 | 35.6 | 4.5 | 13.0 | 46.2 | 48.5 | 35.0 | 27.1 | 16.1 |
| Income Tax Expense | 22.6 | 9.3 | 13.1 | 0.3 | (8.1) | (11.8) | (2.8) | 12.6 | (2.1) | (26.0) | 3.2 | 15.5 | 18.0 | 11.1 | 10.9 | 5.7 |
| Net Income | ||||||||||||||||
| Net Income | 44.7 | 2.1 | 12.5 | (20.4) | 5.6 | 77.8 | 32.2 | 61.3 | 37.7 | 30.5 | 9.8 | 30.8 | 30.5 | 24.0 | 16.2 | 10.4 |
| Per Share | ||||||||||||||||
| Basic EPS | 0.97 | 0.04 | 0.27 | (0.45) | 0.13 | 1.79 | 0.76 | 1.48 | 0.96 | 0.81 | 0.27 | 0.86 | 0.86 | 0.69 | 0.49 | 0.31 |
| Diluted EPS | 0.96 | 0.04 | 0.27 | (0.45) | 0.12 | 1.62 | 0.74 | 1.43 | 0.93 | 0.79 | 0.26 | 0.84 | 0.83 | 0.67 | 0.47 | 0.30 |
| Revenue per Share | 26.77 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 45.9 | 46.0 | 46.0 | 45.2 | 44.4 | 43.5 | 42.6 | 41.5 | 39.2 | 37.5 | 36.2 | 35.9 | 35.7 | 34.7 | 33.3 | 33.1 |
| Diluted Weighted Avg Shares | 46.5 | 46.4 | 46.3 | 45.2 | 45.9 | 47.9 | 43.7 | 42.9 | 40.6 | 38.7 | 36.9 | 36.7 | 36.6 | 35.8 | 34.2 | 34.1 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 84.0 | 82.6 | 52.5 | 84.6 | 162.5 | 96.6 | 131.9 | 95.7 | 62.7 | 79.8 | 74.3 | 69.9 | 53.7 | 40.5 | 24.2 |
| EBIT | 64.7 | 5.2 | 0.3 | (34.9) | (2.3) | 89.5 | 35.5 | 78.4 | 44.4 | 11.1 | 21.4 | 48.6 | 49.6 | 35.3 | 27.1 | 16.2 |
| Effective Tax Rate | 33.6% | — | — | -1.3% | 330.2% | -17.9% | -9.7% | 17.0% | -5.9% | -576.4% | 24.8% | 33.5% | 37.1% | 31.5% | 40.2% | 35.4% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.